These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15151582

  • 1. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity.
    Odd DE, Armstrong DL, Teele RL, Kuschel CA, Harding JE.
    J Paediatr Child Health; 2004; 40(5-6):282-9. PubMed ID: 15151582
    [Abstract] [Full Text] [Related]

  • 2. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
    Rozycki HJ, Byron PR, Elliott GR, Carroll T, Gutcher GR.
    Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
    [Abstract] [Full Text] [Related]

  • 3. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.
    Mieskonen S, Eronen M, Malmberg LP, Turpeinen M, Kari MA, Hallman M.
    Acta Paediatr; 2003 Aug; 92(8):896-904. PubMed ID: 12948063
    [Abstract] [Full Text] [Related]

  • 4. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ, Anbar RD, Mettelman BB.
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [Abstract] [Full Text] [Related]

  • 5. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure.
    Jones RA, Collaborative Dexamethasone Trial Follow-up Group.
    Pediatrics; 2005 Aug; 116(2):379-84. PubMed ID: 16061592
    [Abstract] [Full Text] [Related]

  • 6. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C, Bowling S, Williamson K, McGaw P, Durand M.
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [Abstract] [Full Text] [Related]

  • 7. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease.
    Lodygensky GA, Rademaker K, Zimine S, Gex-Fabry M, Lieftink AF, Lazeyras F, Groenendaal F, de Vries LS, Huppi PS.
    Pediatrics; 2005 Jul; 116(1):1-7. PubMed ID: 15995023
    [Abstract] [Full Text] [Related]

  • 8. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis.
    Onland W, De Jaegere AP, Offringa M, van Kaam AH.
    Pediatrics; 2008 Jul; 122(1):92-101. PubMed ID: 18595991
    [Abstract] [Full Text] [Related]

  • 9. Total steroid dose given to ventilated newborn infants with chronic lung disease.
    Jones BO, Davies MW.
    J Paediatr Child Health; 2007 Jul; 43(1-2):40-3. PubMed ID: 17207054
    [Abstract] [Full Text] [Related]

  • 10. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants.
    Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, Krause-Steinrauf H, Verter J, Korones SB, Lemons JA, Fanaroff AA, Stevenson DK.
    N Engl J Med; 1998 Apr 16; 338(16):1112-8. PubMed ID: 9545359
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease.
    Seth R, Gray PH, Tudehope DI.
    Neonatology; 2009 Apr 16; 95(2):172-8. PubMed ID: 18776732
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.
    Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB, DART Study Investigators.
    Pediatrics; 2007 Apr 16; 119(4):716-21. PubMed ID: 17403842
    [Abstract] [Full Text] [Related]

  • 15. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age.
    O'Shea TM, Washburn LK, Nixon PA, Goldstein DJ.
    Pediatrics; 2007 Sep 16; 120(3):594-602. PubMed ID: 17766533
    [Abstract] [Full Text] [Related]

  • 16. Effect of inhaled corticosteroids on markers of pulmonary inflammation and lung maturation in preterm infants with evolving chronic lung disease.
    Parikh NA, Locke RG, Chidekel A, Leef KH, Emberger J, Paul DA, Stefano JL.
    J Am Osteopath Assoc; 2004 Mar 16; 104(3):114-20. PubMed ID: 15083986
    [Abstract] [Full Text] [Related]

  • 17. Effects of dexamethasone treatment on bone and collagen turnover in preterm infants with chronic lung disease.
    Crofton PM, Shrivastava A, Wade JC, Stephen R, Kelnar CJH, Mcintosh N, Lyon AJ.
    Pediatr Res; 2000 Aug 16; 48(2):155-62. PubMed ID: 10926289
    [Abstract] [Full Text] [Related]

  • 18. Small-bowel perforation in very low birth weight neonates treated with high-dose dexamethasone.
    De Laet MH, Dassonville M, Johansson A, Lerminiaux C, Seghers V, Van den Eijnden S, Blum D, Vanderwinden JM.
    Eur J Pediatr Surg; 2000 Oct 16; 10(5):323-7. PubMed ID: 11194544
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial.
    Bloomfield FH, Knight DB, Harding JE.
    J Pediatr; 1998 Sep 16; 133(3):395-400. PubMed ID: 9738724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.